UB137
TargetsUndisclosed (mAb+Dual-payload)
IndicationsSolid tumour
ClinicalEarly Phase
TherapeuticsOncology
ModalitiesADC
Asset Materials
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →